Pfizer says not facing production issues with COVID-19 vaccine

Pfizer Inc said on Thursday it was not facing any production issues with its COVID-19 vaccine, a day after U.S. officials pointed to challenges with the company’s manufacturing. The company said it was confident in its ability to deliver up to 50 million doses globally this year and up to 1.3 billion next year. “No shipments containing the vaccine are on hold or delayed. This week, we successfully shipped all 2.9 million doses that we were asked to ship by the U.S. Government to the locations specified by them,” Pfizer said in a statement.